Search for a command to run...
Abstract AI-assisted educational and research tools are bridging the gap between computational and experimental neuroscience, allowing scientists to spend less time coding and greater time validating effects inside the laboratory or clinical environment. AI-incorporated neuroimaging systems such as FSL-MEGNet, DeepBrain AI, and FreeSurfer-AI extensions automate structural and purposeful brain image segmentation, parcellation, and function extraction which require substantial preprocessing and scripting. Numerous hours which were obligated to be invested for computational setup can now be utilised constructively as former can be accomplished in minutes through automated pipelines, allowing researchers to allocate greater time to interpretation, speculation, and validation through wet-lab or behavioral assays. In neuropharmacology, AI-driven predictive modelling tools like DeepChem, ChemBERTa, and Molecule.one rapidly are being extensively employed for ligand-goal interactions and pharmacokinetics for neuroprotective compounds. The workflow updates, lengthy molecular docking or dynamic simulation code are now replaced with AI-generation, significantly cutting preclinical screening time for nanoparticle-drug conjugates. In transcriptomics and proteomics, systems such as Gene Ontology AI help, ChatGPT BioQuery, and OmicVerse can analyze huge omics datasets by means of decoding CSV or FASTA inputs through prompts. Such automation reduces the time for statistical coding and visualization, allowing researchers to at once integrate the computational findings to biological pathways validated experimentally. Further, AI-powered meta-analysis tools like Linked Papers AI, Studies Rabbit, and Elicit synthesize masses of courses into thematic maps in seconds; relieving researchers off rigorous literature evaluation. These rapid automated tools pave way for translational choice-making, such as choosing the optimal nanocarrier for BBB penetration or figuring out molecular goals for antioxidant nanomedicine studies. In wet-lab training and translational practice, AI-augmented lab management structures (e.g., BenchSci, LabTwin) automatically interpret experimental protocols and generate reagent lists, tool settings, and expected records formats. Students and researchers can visualize expected assay effects such as DPPH antioxidant curves, FTIR height overlays, or SEM nanoparticle morphology before attempting actual experiments. Collectively, these advances exhibit how AI accelerates pre-clinical lab processings, predictive modeling, and literature synthesis, shifting the research focus from repetitive coding and data cleaning to innovation, experimentation, and translational application. This paradigm shift not only enhances productiveness and reproducibility but also nurtures a generation of neuroscientists who can critically evaluate both computational logic and biological validation; a core pillar for the future of AI-integrated nano biomedicine and brain research. Keywords: Computational Neuroscience, Neuroimaging, Neuropharmacology, Nano biomedicine, Artificial Intelligence
Published in: Shodh Sari-An International Multidisciplinary Journal
Volume 5, Issue 2, pp. 3-25
DOI: 10.59231/sari7912